<DOC>
	<DOCNO>NCT01649479</DOCNO>
	<brief_summary>The main objective study estimate lifetime prevalence major psychiatric disorder ( axis I DSM-IV ; Diagnostic Statistical Manual Mental Disorders , version IV ) large sample patient develop clinical sign pure obstetrical antiphospholipid syndrome ( suspected APS ) .</brief_summary>
	<brief_title>Comparative Prevalence Psychiatric Manifestations Purely Obstetrical Antiphospholipid Syndrome</brief_title>
	<detailed_description>The secondary objective study : A . To compare lifetime prevalence major disorder group ; B . To assess association different , target , qualitative biomarkers clinical symptomatology ; C. To assess association presence `` transitory APS '' presence psychiatric disorder ; D. Estimate compare current prevalence ( = day assessment ) major psychiatric disorder sample patient develop clinical sign obstetrical APS ; E. Estimate current prevalence ( = day assessment ) intensity major depressive episode ( MDE ) sample patient ; F. Compare prevalence current MDE intensity depressive symptom present group ; G. Estimate compare ( lifetime current ) prevalence category psychiatric disorder ( psychotic , anxiety , mood , etc.. ) APS group thrombophilic group remain group ; H. To study average age onset psychiatric disorder clinical manifestation APS sample patient develop clinical sign obstetrical APS ; I . Compare mean age group ; J . Compare mean age onset psychiatric disorder average age first clinical manifestation disease group woman APS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Antiphospholipid Syndrome</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Antiphospholipid</mesh_term>
	<criteria>The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan Not postmenopausal Able understand nature , purpose methodology study agree cooperate clinical biological assessment Available 12 week followup Isolated obstetric morbidity , define least one follow criterion : least three consecutive episode unexplained , early , embryonic miscarriage , occur 10th week pregnancy , normal maternal anatomic hormonal assessment , normal karyotype biological parent ; least one unexplained fetal death , define occur 10th week pregnancy , involve morphologically normal fetus document ultrasound examination direct examination conceptus ; least one premature birth morphologically normal fetus 34th week pregnancy , : ( 1 ) preeclampsia , severe , accord American College Obstetrics Gynecology , ACOG , 2002 ; ( 2 ) document placental insufficiency , define follow parameter : ( 2a ) abnormal nonreassuring fetal monitoring exam , general nonreactive absenceoffetalstress test ( fetal monitoring ) , suggest fetal hypoxemia ; ( 2b ) Doppler examination uterine artery suggest fetal hypoxemia , ie absence enddiastolic flow umbilical artery ; ( 2c ) oligohydramnios , say , amniotic flow index &lt; 5 cm ; ( 2d ) index birth weight gestational age sex 10th percentile . Patient willing accept psychological medical care long term The patient participate another study The patient exclusion period determine previous study The patient judicial protection , tutorship curatorship The patient refuse sign consent It impossible correctly inform patient The patient pregnant , parturient breastfeed Systemic vascular morbidity , define follow criterion : ( 1 ) Any personal history venous thromboembolism , define occurrence deep phlebitis / pulmonary embolism , diagnose mean objective exploration ; ( 2 ) Any personal history superficial venous thrombosis ; ( 3 ) Any personal history clinical , symptomatic relapse arterial insufficiency latter may cerebro vascular nature ( transient ischemic attack , stroke , etc.. ) , coronary nature ( angina , myocardial infarction , etc.. ) otherwise ( claudication mesenteric , etc . ) , objectively diagnose . Systemic inflammatory disease : history systemic disease , lupus erythematosus connective , rheumatoid arthritis Any history neoplastic disease Chronic antithrombotic treatment take occurrence obstetrical complication Any chronic immunosuppressive therapy immunomodulatory therapy ( eg corticosteroid , hydroxochloroquine intravenous immunoglobulin ) Fetal loss explain infectious , metabolic ( include rate fast blood glucose &gt; 7 mmol / L ) , anatomical hormonal factor History infection hepatitis B , hepatitis C HIV Taking antipsychotic treatment potentially implicated biological autoimmune abnormality</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Obstetrical antiphospholipid syndrome</keyword>
	<keyword>Thrombophilia</keyword>
</DOC>